Kodikaz

kodikaz.com

kodikaz.com • 1-10 employees • Likely startup • New

1-10 employees • Likely startup • New

Actively hiring

Cancer Care Centers

Higher Education

Cell & Gene Therapy

As featured in

ITespresso.fr

businesswire

Overview

News

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Team

1-10

employees, estimated range

Backers

Epidarex Capital, Illumina Ventures

Momentum

0/100

no fresh signals

Last sign of life

this month

a posting or a news item

Backed byfrom the funds' portfolios and accelerator catalogs

Epidarex Capital fund Illumina Ventures fund

Similar startupsby what they do, their industry and backers

Arbor Biotechnologies201-500 employees • 2 roles

At Arbor Biotechnologies, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for…

Co., Ltd.

Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…

Restore Vision const embeddedUl = document

Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.

Syntax BioSeries A · 3 mo ago • 51-200 employees

Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.

Nanocellect

Cell sorters by NanoCellect, like the WOLF G2 microfluidic cell sorter, provide gentle sorting analysis for fragile cells. The VERLO cell…

SomagenetixFounded 2019 • 51-200 employees

Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable…

Overview

Kodikaz is a breakthrough pre-clinical gene therapy biotech company. Kodikaz translates cell-recognition and genomic integration mechanisms into curative therapies. Our Zip-Code Technology ™ was discovered in the lab of our scientific founder Dr. Leon Bernal-Mizrachi, at Emory Medical School.

News

Press release ITespresso.fr 2 years ago

AmorChem et la société Kodikaz Therapeutic Solutions, Inc. concluent une entente sur la technologie RNA Zipcodes

Le Fonds AmorChem II S.E.C. ( AmorChem ) a le plaisir d'annoncer que son programme RNA Zipcode a été acquis par Kodikaz

Report

Press release businesswire.com 2 years ago

AmorChem's RNA Zipcode Delivery Technology Investment Exits via New York-Based Kodikaz Therapeutic Solutions, Inc. Read more

Report

Blog 7 years ago

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on Kodikaz.

Report